Skip to main content
. Author manuscript; available in PMC: 2018 Apr 7.
Published in final edited form as: J Proteome Res. 2017 Mar 8;16(4):1763–1772. doi: 10.1021/acs.jproteome.7b00024

Figure 5.

Figure 5

Changes in exosomal cargo in response to treatment with chemoradiotherapy. Treatment-induced changes in the expression of (a) OBSL1, (b) PLF4, (c) MARE2, (d) 1B51, (e) PARVB, (f) CD71, (g) vimentin, and (h) LYSC. Protein expression was evaluated in exosomes derived from healthy controls (T0) and patients prior to treatment (T1), after chemotherapy (T2) and at the midpoint of a cycle of chemoradiotherapy (T3).